Amgen (AMGN) |
United States |
$140.221B |
16.15 |
CSL (CSLLY) |
Australia |
$87.693B |
0.00 |
Gilead Sciences (GILD) |
United States |
$85.562B |
10.60 |
Vertex Pharmaceuticals (VRTX) |
United States |
$56.714B |
57.89 |
Biogen (BIIB) |
United States |
$53.023B |
9.10 |
Illumina (ILMN) |
United States |
$47.333B |
51.93 |
Regeneron Pharmaceuticals (REGN) |
United States |
$40.861B |
17.89 |
Actelion (ALIOF) |
Switzerland |
$29.891B |
0.00 |
Alexion Pharmaceuticals (ALXN) |
United States |
$24.889B |
12.29 |
Incyte (INCY) |
United States |
$20.000B |
46.42 |
Seattle Genetics (SGEN) |
United States |
$19.240B |
0.00 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$16.114B |
0.00 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.532B |
0.00 |
Genmab (GNMSF) |
Denmark |
$13.473B |
59.51 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$13.447B |
0.00 |
Galapagos (GLPG) |
Belgium |
$11.816B |
30.44 |
Exact Sciences (EXAS) |
United States |
$11.090B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$10.822B |
51.94 |
QIAGEN (QGEN) |
Netherlands |
$9.359B |
30.51 |
BeiGene (BGNE) |
Cayman Islands |
$8.604B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$8.320B |
55.69 |
Amarin (AMRN) |
Ireland |
$8.212B |
0.00 |
Sarepta Therapeutics (SRPT) |
United States |
$7.489B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$6.857B |
0.00 |
Guardant Health (GH) |
United States |
$6.811B |
0.00 |
BioNTech SE (BNTX) |
Germany |
$6.752B |
0.00 |
Medicines (MDCO) |
United States |
$6.699B |
0.00 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$6.151B |
15.64 |
Moderna (MRNA) |
United States |
$6.148B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$6.086B |
0.00 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$5.943B |
0.00 |
Exelixis (EXEL) |
United States |
$5.363B |
15.09 |
Ascendis Pharma (ASND) |
Denmark |
$4.958B |
0.00 |
Bluebird Bio (BLUE) |
United States |
$4.651B |
0.00 |
Repligen (RGEN) |
United States |
$4.640B |
84.08 |
China Biologic Products (CBPO) |
China |
$4.594B |
25.88 |
MorphoSys AG (MOR) |
Germany |
$4.535B |
0.00 |
Spark Therapeutics (ONCE) |
United States |
$4.259B |
0.00 |
Mirati Therapeutics (MRTX) |
United States |
$4.185B |
0.00 |
Immunomedics (IMMU) |
United States |
$4.008B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$3.938B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$3.795B |
0.00 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$3.645B |
0.00 |
Blueprint Medicines (BPMC) |
United States |
$3.629B |
0.00 |
Alkermes (ALKS) |
Ireland |
$3.347B |
0.00 |
MyoKardia (MYOK) |
United States |
$3.017B |
0.00 |
UniQure (QURE) |
Netherlands |
$3.005B |
0.00 |
Genmab (GMAB) |
Denmark |
$2.859B |
5.89 |
Emergent Biosolutions (EBS) |
United States |
$2.789B |
27.71 |
NeoGenomics (NEO) |
United States |
$2.779B |
147.89 |
Halozyme Therapeutics (HALO) |
United States |
$2.743B |
0.00 |
Acceleron Pharma (XLRN) |
United States |
$2.650B |
0.00 |
Zai Lab (ZLAB) |
China |
$2.500B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$2.468B |
0.00 |
Amicus Therapeutics (FOLD) |
United States |
$2.423B |
0.00 |
Arena Pharmaceuticals (ARNA) |
United States |
$2.371B |
5.52 |
RA PHARMCTL INC (RARX) |
United States |
$2.232B |
0.00 |
Insmed (INSM) |
United States |
$2.067B |
0.00 |
Ligand Pharmaceuticals (LGND) |
United States |
$1.876B |
36.10 |
Myriad Genetics (MYGN) |
United States |
$1.860B |
27.47 |
Akcea Therapeutics (AKCA) |
United States |
$1.830B |
0.00 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$1.829B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$1.799B |
0.00 |
Zymeworks (ZYME) |
Canada |
$1.688B |
0.00 |
Momenta Pharmaceuticals (MNTA) |
United States |
$1.667B |
0.00 |
Principia Biopharma (PRNB) |
United States |
$1.625B |
0.00 |
Epizyme (EPZM) |
United States |
$1.622B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.546B |
0.00 |
Editas Medicine (EDIT) |
United States |
$1.546B |
0.00 |
Arvinas (ARVN) |
United States |
$1.456B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$1.430B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.395B |
0.00 |
Innoviva (INVA) |
United States |
$1.386B |
4.08 |
Alector (ALEC) |
United States |
$1.374B |
0.00 |
Athenex (ATNX) |
United States |
$1.315B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.280B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$1.247B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.129B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$1.088B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$1.025B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$1.006B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$0.992B |
0.00 |
Codexis (CDXS) |
United States |
$0.926B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.918B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.906B |
7.61 |
Achillion Pharmaceuticals (ACHN) |
United States |
$0.870B |
0.00 |
Twist Bioscience (TWST) |
United States |
$0.861B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.838B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$0.822B |
0.00 |
Vericel (VCEL) |
United States |
$0.794B |
296.17 |
MiMedx (MDXG) |
United States |
$0.791B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.780B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.763B |
24.77 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.749B |
12.77 |
Revance Therapeutics (RVNC) |
United States |
$0.742B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.736B |
0.00 |
Heska (HSKA) |
United States |
$0.733B |
187.20 |
UROGEN PHARMA (URGN) |
United States |
$0.698B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$0.691B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$0.686B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.678B |
0.00 |
Adverum Biotechnologies (ADVM) |
United States |
$0.678B |
0.00 |
Mesoblast (MESO) |
Australia |
$0.664B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$0.656B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.624B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.615B |
0.00 |
Retrophin (RTRX) |
United States |
$0.594B |
0.00 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.590B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$0.584B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.578B |
0.00 |
Cytokineticsorporated (CYTK) |
United States |
$0.572B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$0.548B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.539B |
3.73 |
Agenus (AGEN) |
United States |
$0.526B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.522B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.517B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.514B |
0.00 |
Stemline Therapeutics (STML) |
United States |
$0.511B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.496B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.460B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.439B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$0.413B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$0.410B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.402B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.392B |
9.80 |
Bellus Health (BLU) |
Canada |
$0.389B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.384B |
0.00 |
AMAG Pharmaceuticals (AMAG) |
United States |
$0.384B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.368B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.362B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.362B |
0.00 |
Pfenex (PFNX) |
United States |
$0.353B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.331B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.323B |
0.00 |
Cellular Biomedicine (CBMG) |
United States |
$0.322B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.322B |
0.00 |
Aquinox Pharmaceuticals (NLTX) |
United States |
$0.319B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$0.311B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$0.305B |
0.00 |
Geron (GERN) |
United States |
$0.300B |
0.00 |
Kamada (KMDA) |
Israel |
$0.297B |
8.67 |
MannKind (MNKD) |
United States |
$0.289B |
0.00 |
Compugen (CGEN) |
Israel |
$0.287B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.285B |
0.00 |
Exicure (XCUR) |
United States |
$0.277B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$0.271B |
0.00 |
Cel-Sci (CVM) |
United States |
$0.267B |
0.00 |
Albireo Pharma (ALBO) |
United States |
$0.266B |
0.00 |
IVERIC Bio (ISEE) |
United States |
$0.264B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.259B |
0.00 |
Senesco Technologies (ELOX) |
United States |
$0.253B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.246B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.240B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.235B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.232B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.231B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.221B |
0.00 |
NantKwest (NK) |
United States |
$0.216B |
0.00 |
Proteostasis Therapeutics (PTI) |
United States |
$0.210B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.209B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.204B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.203B |
0.00 |
XOMA (XOMA) |
United States |
$0.202B |
0.00 |
Athersys (ATHX) |
United States |
$0.202B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$0.199B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.196B |
0.00 |
Cerecor (CERC) |
United States |
$0.194B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.190B |
0.00 |
Affimed (AFMD) |
Germany |
$0.190B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.190B |
0.00 |
Palatin Technologies (PTN) |
United States |
$0.186B |
5.06 |
Mersana Therapeutics (MRSN) |
United States |
$0.183B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.176B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$0.170B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.165B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.163B |
0.00 |
Alcobra (ARCT) |
United States |
$0.162B |
0.00 |
Dyadic (DYAI) |
United States |
$0.162B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.158B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.144B |
0.00 |
Aptinyx (APTX) |
United States |
$0.142B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.139B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.138B |
0.00 |
Arsanis (XFOR) |
United States |
$0.136B |
0.00 |
Arbutus Biopharma (ABUS) |
Canada |
$0.136B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$0.135B |
0.00 |
Newron Pharmaceuticals SpA (NWPHF) |
Italy |
$0.134B |
0.00 |
Prometic Life Sciences (LMNL) |
Canada |
$0.132B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.130B |
0.00 |
TELA Bio (TELA) |
United States |
$0.128B |
0.00 |
Nicox SA (NICXF) |
France |
$0.125B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.122B |
0.00 |
SESEN BIO, INC (SESN) |
United States |
$0.114B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.113B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.111B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.107B |
0.00 |
Menlo Therapeutics (MNLO) |
United States |
$0.106B |
0.00 |
Novavax (NVAX) |
United States |
$0.106B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.103B |
0.00 |
BioTime (LCTX) |
United States |
$0.103B |
5.28 |
Verastem (VSTM) |
United States |
$0.101B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.099B |
2.65 |
Aduro Biotech (ADRO) |
United States |
$0.095B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.088B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$0.088B |
0.00 |
Synlogic (SYBX) |
United States |
$0.087B |
0.00 |
Adocia (ADOCY) |
France |
$0.086B |
0.00 |
OvaScience (MLND) |
United States |
$0.084B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.082B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.082B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.078B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.078B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.077B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.071B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.071B |
0.00 |
Trevena (TRVN) |
United States |
$0.071B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.068B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.066B |
0.00 |
Catabasis Pharmaceuticals (CATB) |
United States |
$0.066B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.066B |
0.00 |
Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.065B |
0.00 |
Merrimack Pharmaceuticals (MACK) |
United States |
$0.060B |
0.00 |
NewLink Genetics (NLNK) |
United States |
$0.060B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.060B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.055B |
0.00 |
Curis (CRIS) |
United States |
$0.051B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.049B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.049B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.047B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.045B |
2.92 |
AquaBounty Technologies (AQB) |
United States |
$0.044B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.042B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.042B |
0.00 |
AmpliPhi Biosciences (ARMP) |
United States |
$0.041B |
0.00 |
Aridis Pharmaceuticals (ARDS) |
United States |
$0.041B |
0.00 |
Protalix BioTherapeutics (PLX) |
Israel |
$0.041B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.040B |
0.00 |
Evogene (EVGN) |
Israel |
$0.039B |
0.00 |
AIT Therapeutics (XAIR) |
United States |
$0.039B |
0.00 |
Celsion (CLSN) |
United States |
$0.036B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$0.035B |
0.00 |
Sunesis Pharmaceuticals (SNSS) |
United States |
$0.034B |
0.00 |
Stellar Biotechnologies (EDSA) |
Canada |
$0.034B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.032B |
0.00 |
Apricus Biosciences (SEEL) |
United States |
$0.031B |
0.00 |
VIVUS (VVUS) |
United States |
$0.029B |
0.00 |
Fibrocell Science Inc (FCSC) |
United States |
$0.029B |
16.67 |
BioCardia (BCDA) |
United States |
$0.028B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.028B |
0.00 |
Novogen (KZIA) |
Australia |
$0.028B |
0.00 |
INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.028B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$0.027B |
0.00 |
Caladrius Biosciences (CLBS) |
United States |
$0.026B |
0.00 |
Soligenix (SNGX) |
United States |
$0.026B |
0.00 |
VistaGen Therapeutics (VTGN) |
United States |
$0.025B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.023B |
0.00 |
PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.023B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.021B |
0.00 |
Signal Genetics (MGEN) |
United States |
$0.020B |
0.00 |
CollPlant Holdings (CLGN) |
Israel |
$0.020B |
0.00 |
Unum Therapeutics (UMRX) |
United States |
$0.017B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.017B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.017B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.016B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.014B |
0.00 |
MYOS RENS Technology (MYOS) |
United States |
$0.013B |
0.00 |
TOCAGEN INC (TOCA) |
United States |
$0.013B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.012B |
0.00 |
Advaxis (ADXS) |
United States |
$0.011B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.011B |
0.00 |
TrovaGene (TROV) |
United States |
$0.010B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.010B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.010B |
0.00 |
Cesca Therapeutics (THMO) |
United States |
$0.008B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.008B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.008B |
0.00 |
IBio (IBIO) |
United States |
$0.008B |
0.00 |
Benitec Biopharma (BNTC) |
Australia |
$0.007B |
0.00 |
BioPharmX (BPMX) |
United States |
$0.005B |
0.00 |
Neuralstem (SNCA) |
United States |
$0.003B |
0.00 |